HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 224 filers reported holding HORIZON PHARMA PLC in Q3 2018. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $740,000 | +85.0% | 28,000 | +36.6% | 0.00% | +50.0% |
| Q4 2018 | $400,000 | +58.7% | 20,500 | +58.9% | 0.00% | +100.0% |
| Q3 2018 | $252,000 | +41.6% | 12,900 | +19.4% | 0.00% | 0.0% |
| Q2 2018 | $178,000 | +102.3% | 10,800 | +74.2% | 0.00% | – |
| Q1 2018 | $88,000 | -2.2% | 6,200 | 0.0% | 0.00% | – |
| Q4 2017 | $90,000 | -15.1% | 6,200 | -31.1% | 0.00% | – |
| Q2 2017 | $106,000 | -20.3% | 9,000 | 0.0% | 0.00% | -100.0% |
| Q1 2017 | $133,000 | -26.5% | 9,000 | -19.6% | 0.00% | 0.0% |
| Q4 2016 | $181,000 | -54.2% | 11,200 | -48.6% | 0.00% | -50.0% |
| Q3 2016 | $395,000 | +14.5% | 21,800 | +3.8% | 0.00% | 0.0% |
| Q2 2016 | $345,000 | -79.5% | 21,000 | -75.3% | 0.00% | -75.0% |
| Q3 2015 | $1,684,000 | +207.3% | 85,000 | +90.6% | 0.01% | +700.0% |
| Q3 2014 | $548,000 | – | 44,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,609,894 | $109,460,000 | 3.84% |
| Avoro Capital Advisors LLC | 5,593,683 | $92,631,000 | 3.57% |
| Broadfin Capital, LLC | 1,339,575 | $22,183,000 | 3.49% |
| SCOPIA CAPITAL MANAGEMENT LP | 11,912,290 | $197,268,000 | 3.45% |
| JW Asset Management, LLC | 270,775 | $4,484,000 | 2.86% |
| Rhenman & Partners Asset Management AB | 1,632,212 | $27,029,000 | 2.77% |
| Paulson & Co. | 7,670,700 | $127,027,000 | 2.60% |
| Redwood Investments, LLC | 1,315,149 | $21,779,000 | 1.50% |
| KOPP INVESTMENT ADVISORS LLC | 93,220 | $1,544,000 | 1.45% |
| 1492 Capital Management LLC | 72,951 | $1,208,000 | 0.86% |